HDAC6 and ciliopathy: Our data, together with previous findings that HDAC6 inhibitors could rescue various ciliary defects caused by the upregulation of HDAC6 expression or activity9, 10, 11, 12, 13, 16, 41, suggest that the therapeutic value of this class of agents for the treatment of HDAC6-associated ciliopathies merits further investigation.